| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.4M | +33.0% | +271.8% |
| Cost of Revenue | $731K | +6.6% | +124.2% |
| Gross Profit | $720K | +78.2% | +1025.0% |
| R&D Expense | $446K | +17.7% | +36.4% |
| SG&A Expense | $504K | -20.8% | +64.7% |
| Operating Income | -$2.0M | -3.3% | -25.2% |
| Net Income | -$2.1M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $6.4M | -17.2% | — |
| Accounts Receivable | $1.4M | +179.8% | — |
| Inventory | $322K | -16.4% | — |
| Current Assets | $8.4M | -5.1% | — |
| Total Assets | $8.7M | -4.2% | — |
| Current Liabilities | $1.9M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$5.7M | — | — |
| Capital Expenditures | $256K | — | — |
| Investing Cash Flow | -$256K | — | — |
| Financing Cash Flow | $12.3M | — | — |
| Free Cash Flow | -$5.9M | — | — |
| -2.7% |
| -20.1% |
| +88.8% |
| — |
| Total Liabilities | $1.9M | +88.8% | — |
| Stockholders' Equity | $6.8M | -15.7% | +1402.7% |